Cutaneous pseudolymphoma related to violet tattoo ink successfully treated with intralesional corticosteroid

Ital J Dermatol Venerol. 2022 Jun;157(3):290-291. doi: 10.23736/S2784-8671.21.07064-X. Epub 2021 Jul 20.

Authors

Corrado Zengarini¹, Tiziano Ferrari², Gionathan Orioni¹, Martina Mussi¹, Annalisa Patrizi¹, Cosimo Misciali¹, Beatrice Raone¹

Affiliations

¹ Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, IRCCS Policlinico S. Orsola-Malpighi, Alma Mater Studiorum - Università di Bologna, Bologna, Italy.
² Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, IRCCS Policlinico S. Orsola-Malpighi, Alma Mater Studiorum - Università di Bologna, Bologna, Italy - tiziano.ferrari3@studio.unibo.it.

PMID: 34282865
DOI: 10.23736/S2784-8671.21.07064-X

No abstract available

MeSH terms

Adrenal Cortex Hormones
Humans
Ink
Pseudolymphoma* / chemically induced
Skin Diseases* / drug therapy
Tattooing* / adverse effects

Substances

Adrenal Cortex Hormones